Show simple item record

dc.contributor.authorMiddleton, Kirsten;
dc.contributor.authorZhang, Guo-ping;
dc.contributor.authorGeorge, Thomas
dc.date.accessioned2012-05-21T18:21:37Z
dc.date.accessioned2015-10-05T14:44:07Z
dc.date.available2012-05-21T18:21:37Z
dc.date.available2015-10-05T14:44:07Z
dc.date.issued2012-05-21T18:21:37Z
dc.identifier.urihttp://hdl.handle.net/10484/4025
dc.description.abstractAlzheimer’s Disease is the 5th leading cause of death for Americans 65 and older Treatment The U.S. Food and Drug Administration Only five drugs approved that “temporarily slow worsening of symptoms for about six to 12 months.” Effective for only about half of all patients
dc.language.isoen_US
dc.subjectAlzheimer's disease
dc.subjectMemantine's role
dc.titleElectronic properties of memantine(Alzheimer's disease)and amantadine(anti-flu)drugs.
dc.date.published2012
dc.description.departmentchemistry and physics
dc.description.facultysponsorGuo-ping Zhang
dc.description.itemidcsrcILL-ETD-004
refterms.dateFOA2021-06-02T11:46:30Z


Files in this item

Thumbnail
Name:
APS Presentation Finished.pptx
Size:
515.8Kb
Format:
Microsoft PowerPoint 2007

This item appears in the following Collection(s)

Show simple item record